Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 3 boards, counting each seat separately. Longest: Kyntra Bio Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Calidi Biotherapeutics Inc. July 9, 202584.9%
-
Calidi Biotherapeutics Inc. August 28, 2023100.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 21, 2025 | Calidi Biotherapeutics Inc. | Open-market purchase | +75,000 | $2.00 | $150,000 |
| Jun 30, 2025 | Kyntra Bio Inc. | Open-market purchase | +23,567 | $5.07 | $119,485 |
| Mar 21, 2025 | Kyntra Bio Inc. | Open-market purchase | +50,000 | $0.34 | $17,000 |
| Mar 20, 2025 | Kyntra Bio Inc. | Open-market purchase | +250,000 | $0.35 | $87,500 |
| Jun 28, 2024 | Calidi Biotherapeutics Inc. | Grant or award | +79,687 | — | — |
| Jun 3, 2024 | Calidi Biotherapeutics Inc. | Option exercise | +173,000 | $0.20 | $34,600 |
| Jun 3, 2024 | Calidi Biotherapeutics Inc. | Option exercise | +375,000 | $0.20 | $75,000 |
| Apr 18, 2024 | Calidi Biotherapeutics Inc. | Grant or award | +375,000 | $0.40 | $150,000 |
| Mar 29, 2024 | Calidi Biotherapeutics Inc. | Grant or award | +28,207 | — | — |
| Dec 21, 2023 | Calidi Biotherapeutics Inc. | Grant or award | +10,625 | $1.80 | $19,125 |
| Jun 7, 2023 | Kyntra Bio Inc. | Grant or award | +8,289 | — | — |
| Jun 7, 2023 | Kyntra Bio Inc. | Open-market sale | −7,100 | $18.03 | $128,013 |
Questions about James A. Schoeneck
What boards is James A. Schoeneck on?
James A. Schoeneck sits on the boards of Calidi Biotherapeutics Inc., Connect Biopharma Holdings Limited and Kyntra Bio Inc.
How long has James A. Schoeneck served on boards?
Our records show at least 7 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.